article · International Journal of Drug Delivery Technology
Background Chronic gluteal and lower back discomfort, often caused by piriformis syndrome, may severely limit a person's ability to carry out daily tasks. While there is encouraging evidence for the use of non-invasive modalities like radial extracorporeal shockwave therapy (rESWT) and low-level laser therapy (LLLT) to treat musculoskeletal conditions, there is a lack of comparative evidence regarding the efficacy of these therapies, particularly when combined with therapeutic exercise. Methods There were 70 participants in the experiment, split equally between two groups, and it was a prospective randomised controlled trial: Compare the Use of Shockwaves with Lasers for Exercise. Treatments were administered for a duration of four weeks. Baseline, post-treatment, and 3-month follow-up assessments of the following outcome measures were conducted: Visual Analogue Scale (VAS), Oswestry Disability Index (ODI), range of motion (ROM), and Short Form-36 (SF-36). Results There were significant improvements in pain and disability levels (p < 0.001) in both groups. There were significant time × group interactions for VAS, ODI, and hip ROM, and shockwave treatment produced better functional improvements in ODI (mean reduction: 15.80 vs. 11.71, p = 0.049) and hip ROM (mean increase: 15.43° vs. 9.91°, p = 0.063). Conclusion When exercised with LLLT or rESWT, piriformis syndrome may be safely and effectively treated. When compared to other methods, shockwave treatment improved functional recovery and mobility the most.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.25258/ijddt.16.62s.59
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.